Life sciences · Journal article
Virulence · September 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Mosquito-borne diseases pose a threat to global public health, yet traditional control measures are constrained by insecticide resistance and vaccine development bottlenecks. The gut microbiota-mediated transmission-blocking strategy has emerged as a promising alternative. This review summarizes three symbiont mechanisms: direct pathogen inhibition, host immunomodulation, and metabolic niche competition. We highlight research progress and field efficacy of three technical routes: Wolbachia-based population replacement and suppression, paratransgenesis using engineered symbionts, and deployment of natural probiotics. In large-scale field trials, this strategy achieved a 77.1% reduction in dengue incidence and an 86.2% reduction in dengue-related hospitalizations. We analyze constraints including temperature sensitivity, viral evolutionary escape, and ecological safety risks, and propose future directions emphasizing multi-strategy synergy, multi-effector engineered symbionts, and artificial intelligence (AI)-assisted precision interventions. Aligned with the One Health framework, this microbiota-based paradigm offers a foundation for sustainable mosquito-borne disease control, although large-scale implementation depends on resolving regulatory, ecological-safety, and scalability challenges.